Management of Traumatic Brain Injury Sequelae With Alpha-2 Adrenergic Receptor Agonists.

IF 3.3 3区医学 Q2 CLINICAL NEUROLOGY

Journal of Head Trauma Rehabilitation Pub Date : 2025-08-22 DOI:10.1097/HTR.0000000000001099

Jamie L Ott, Thomas K Watanabe

引用次数: 0

Abstract

Objective: To describe clinical uses of the class of alpha-2 receptor agonist medications in the treatment of traumatic brain injury sequelae. Clinicians treating patients with traumatic brain injuries (TBI) will often see patients who have been prescribed alpha-2 agonists or may consider initiating use.

Design: Narrative review.

Conclusion: This class of medication has a number of different indications (and side effects), and drugs within this class also have some unique properties that can be important factors in clinical decision-making. Although this class of medications has been available for many years, there is still much emerging information that is pertinent for the treatment of patients with TBI.

查看原文本刊更多论文

α -2肾上腺素能受体激动剂治疗创伤性脑损伤后遗症。

目的：介绍α -2受体激动剂类药物在颅脑外伤后遗症治疗中的临床应用。治疗创伤性脑损伤（TBI）患者的临床医生经常会看到已经开过α -2激动剂或可能考虑开始使用的患者。设计：叙述回顾。结论：这类药物有许多不同的适应症（和副作用），这类药物也有一些独特的性质，可以成为临床决策的重要因素。尽管这类药物已经可用多年，但仍有许多与TBI患者治疗相关的新信息。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Head Trauma Rehabilitation 医学-康复医学

CiteScore

4.80

自引率

4.20%

发文量

153

审稿时长

6-12 weeks

期刊介绍： The Journal of Head Trauma Rehabilitation is a leading, peer-reviewed resource that provides up-to-date information on the clinical management and rehabilitation of persons with traumatic brain injuries. Six issues each year aspire to the vision of “knowledge informing care” and include a wide range of articles, topical issues, commentaries and special features. It is the official journal of the Brain Injury Association of America (BIAA).